Inhaled beclomethasone/formoterol in idiopathic pulmonary fibrosis: a randomised controlled exploratory study

Inhaled beclomethasone/formoterol in idiopathic pulmonary fibrosis: a randomised controlled exploratory study

Bibliographic Details
Main Authors:	Caroline E. Wright, Simon D. Fraser, Kayleigh Brindle, Alyn H. Morice, Simon P. Hart, Michael G. Crooks
Format:	Article
Language:	English
Published:	European Respiratory Society 2017-12-01
Series:	ERJ Open Research
Online Access:	http://openres.ersjournals.com/content/3/4/00100-2017.full

Similar Items

COMPARATIVE EFFICACY OF INHALED DRUGS FORMOTEROL / BECLOMETHASONE AND FORMOTEROL / BUDESONIDE AND BRONCHIAL ASTHMA
by: V. A. Nikitin, et al.
Published: (2016-03-01)

Breathomics for Assessing the Effects of Treatment and Withdrawal With Inhaled Beclomethasone/Formoterol in Patients With COPD
by: Paolo Montuschi, et al.
Published: (2018-04-01)

Increased platelet reactivity in idiopathic pulmonary fibrosis is mediated by a plasma factor.
by: Michael G Crooks, et al.
Published: (2014-01-01)

Rapid effects of extrafine beclomethasone dipropionate/formoterol fixed combination inhaler on airway inflammation and bronchoconstriction in asthma: a randomised controlled trial
by: O'Connor Brian J, et al.
Published: (2011-12-01)

Azithromycin for sarcoidosis cough: an open-label exploratory clinical trial
by: Simon D. Fraser, et al.
Published: (2020-11-01)

Extrafine combination beclomethasone dipropionate/ formoterol therapy in obstructive lung diseases
by: I. N. Trofimenko, et al.
Published: (2020-08-01)

Effects of inhaled beclomethasone dipropionate/formoterol fumarate/glycopyrronium on diaphragmatic workload and lung function in uncontrolled asthma: a case report
by: Antonio Maiorano, et al.
Published: (2024-03-01)

Management of severe COPD exacerbations: focus on beclomethasone dipropionate/formoterol/glycopyrronium bromide
by: Mantero M, et al.
Published: (2018-07-01)

Coagulation and anticoagulation in idiopathic pulmonary fibrosis
by: Michael G. Crooks, et al.
Published: (2015-09-01)

Small Airways, Big Problem: Extrafine beclomethasone/formoterol in asthma and chronic obstructive pulmonary disease
by: Ashfaq Hasan, et al.
Published: (2021-01-01)

Beclomethasone dipropionate and formoterol fumarate synergistically interact in hyperresponsive medium bronchi and small airways
by: Luigino Calzetta, et al.
Published: (2018-04-01)

Comparison of Dry-Powder Inhaler and Pressurized Metered-Dose Inhaler Formulations of Extrafine Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrronium in Patients with COPD: The TRI-D Randomized Controlled Trial
by: Beeh KM, et al.
Published: (2021-01-01)

Chronic cough in cystic fibrosis: the effect of modulator therapy on objective 24-h cough monitoring
by: Mengru Zhang, et al.
Published: (2022-05-01)

Formulation and evaluation of CFC free inhalers for beclomethasone dipropionate
by: Gopala Krishna Murthy Talasila, et al.
Published: (2013-06-01)

Efficacy and safety of a novel beclomethasone dipropionate dry powder inhaler (Clickhaler (R)) for the treatment of adult asthma
by: Stradling, JR, et al.
Published: (2000)

Equivalence of hydrofluoroalkane (HFA) and chlorofluorocarbons (CFC) formulations of inhaled beclomethasone.
by: Lipworth, B, et al.
Published: (2000)

Inhaled Beclomethasone with or whiteout Montelukast in the Management of Pediatric Persistent Asthma
by: I Mohammadzadeh, et al.
Published: (2018-07-01)

Subcutaneous octreotide as a therapeutic option for refractory chronic cough: subjective response pattern and adverse effects from a retrospective single-centre case series
by: Kayleigh Brindle, et al.
Published: (2023-05-01)

Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review
by: Halpin David MG, et al.
Published: (2006-06-01)

Comparing the clinical efficacy and safety of high doses of beclomethasone inhaler with medium doses of beclomethasone inhaler combined with oral aminophylline or montelukast tablets in persistent asthmatic Iraqi patients.
by: Ali L. Jassim, et al.
Published: (2011-06-01)

Penggunaan Extrafine Beclometason Diproprionat/Formoterol Fumarat pada PPOK [Combined Extrafine Beclomethason Diproprionat/Formoteral Fumarat in COPD]
by: Sakinatus Syarifah, et al.
Published: (2019-05-01)

Extrafine HFA-beclomethasone-formoterol vs. nonextrafine combination of an inhaled corticosteroid and a long acting β2-agonist in patients with persistent asthma: A systematic review and meta-analysis.
by: Ting Liu, et al.
Published: (2021-01-01)

Real-life therapeutic effects of beclomethasone dipropionate/formoterol fumarate/glycopyrronium combined triple therapy in patients with chronic obstructive pulmonary disease
by: Corrado Pelaia, et al.
Published: (2023-02-01)

Efficacy and safety of a novel beclomethasone dipropionate dry powder inhaler (Clickhaler) for the treatment of adult asthma. Amsterdam Clinical Study Group.
by: Stradling, JR, et al.
Published: (2000)

A feasibility, randomised controlled trial of a complex breathlessness intervention in idiopathic pulmonary fibrosis (BREEZE-IPF): study protocol
by: Caroline Wright, et al.
Published: (2019-10-01)

Inhalation of Budesonide/Formoterol Increases Diaphragm Muscle Contractility
by: Chiyohiko Shindoh, et al.
Published: (2012-01-01)

Eficácia do formoterol na reversão imediata do broncoespasmo Efficacy of inhaled formoterol in reversing bronchoconstriction
by: Adalberto Sperb Rubin, et al.
Published: (2006-06-01)

Inhaled formoterol impairs aerobic exercise capacity in endurance-trained individuals: a randomised controlled trial
by: Søren Jessen, et al.
Published: (2023-04-01)

Comparison of the effect of high-dose inhaled budesonide and fluticasone on adrenal function in patients with severe chronic obstructive pulmonary disease
by: Ahmed Fahim, et al.
Published: (2012-01-01)

Protective effect of budesonide/formoterol compared with formoterol, salbutamol and placebo on repeated provocations with inhaled AMP in patients with asthma: a randomised, double-blind, cross-over study
by: van der Woude Hanneke J, et al.
Published: (2010-05-01)

Inhaled beclomethasone in the treatment of early COVID-19: a double-blind, placebo-controlled, randomised, hospital-based trial in Sri Lanka
by: Chamila Mettananda, et al.
Published: (2023-12-01)

The “vicious circle” of chronic cough: the patient experience – qualitative synthesis
by: Kayleigh Brindle, et al.
Published: (2023-05-01)

The topical study of inhaled drug (salbutamol) delivery in idiopathic pulmonary fibrosis
by: Omar S. Usmani, et al.
Published: (2018-02-01)

The efficacy of extrafine beclomethasone dipropionate–formoterol fumarate in COPD patients who are not "frequent exacerbators": a post hoc analysis of the FORWARD study
by: Singh D, et al.
Published: (2017-11-01)

Study design and rationale for the TETON phase 3, randomised, controlled clinical trials of inhaled treprostinil in the treatment of idiopathic pulmonary fibrosis
by: Vincent Cottin, et al.
Published: (2022-07-01)

Validation of a simplified-geometry model of inhaled formoterol pharmacodynamics in asthmatic patients
by: Simona Panunzi, et al.
Published: (2022-12-01)

Long-term maintenance of pediatric asthma: focus on budesonide/formoterol inhalation aerosol
by: Peter N Huynh, et al.
Published: (2010-02-01)

Salvianolic acid B dry powder inhaler for the treatment of idiopathic pulmonary fibrosis
by: Peng Lu, et al.
Published: (2022-05-01)

Acute exacerbation of idiopathic pulmonary fibrosis after inhalation of a water repellent
by: David Bennett, et al.
Published: (2015-08-01)

Efficacy and safety of single-inhaler triple therapy of glycopyrronium, formoterol and fluticasone in patients with COPD: a double-blind, randomised controlled trial
by: Sundeep Salvi, et al.
Published: (2021-07-01)